Pharmacoeconomics is the scientific discipline that evaluates the clinical, economic, and humanistic aspects of pharmaceutical products, services, and programs, as well as other health care interventions to provide health care decision makers, providers and patients with information needed to efficiently allocate health care resources..
Pharmacoeconomics involves the application of a variety of scientific disciplines, including health economics, epidemiology, statistics, and decision science. Elements of a pharmacoeconomic analysis may incorporate evaluations of clinical safety and efficacy, comparative effectiveness, meta-analysis, health-related quality of life, epidemiology, decision sciences, and health services research.
Examples of pharmacoeconomic research include:
- economic evaluation of alternative medical and other therapies;
- assessment of patients’ willingness to pay for health care interventions;
- elicitation of quality of life and health state utilities.
For further information about Pharmacoeconomics, please visit the following sites:
Pharmacoeconomics at UF
 International Society for Pharmacoeconomics and Outcomes Research. Available at: http://www.ispor.org/terminology/default.asp